Your Gulf file: search another company
Gulf file
RETAJ PHARMACEUTICAL INDUSTRIES
Jordan
Read 20 Oct 2026 from the SFDA drug company register and the EDE medicines directory. Is this your company, and is something wrong? Tell us.
Saudi Arabia
- Register entry
- RETAJ PHARMACEUTICALS INDUSTRIES - JORDAN
- SFDA status
- Cancelled
- Registration
- 2018/5239
- Type
- human medicines
- Production lines
- 2
Show
CEPHALOSPORIN - CAPSULE , HARD SHELL; CEPHALOSPORIN - POWDER FOR SUSPENSIONS
- Source
- SFDA register page
102 tenders from Saudi government health buyers are open today (16 NUPCO, 86 Etimad). The tender watch checks each new one against your products and tells you which your agent can bid.
United Arab Emirates
- Entries in the directory
- 3
- Classes
- Conventional Medicines
- First registered
- 31 Aug 2020
- UAE agents
- AZALEA PHARMA LLC (3)
The second-agent rule applies to you. Since 24 Feb 2026 the EDE requires more than one authorised agent per medical product. Every one of your 3 directory entries goes through one agent.
UAE products
| Product | Form | Class | Dispensing | Registered | Agent |
|---|---|---|---|---|---|
| APEX 100 mg/5 ml (listed 2 times) | Suspension | Conventional Medicines | Prescription Only Medicine (POM) | 31 Aug 2020 | AZALEA PHARMA LLC |
| APEX® 400 | Capsule | Conventional Medicines | Prescription Only Medicine (POM) | 31 Aug 2020 | AZALEA PHARMA LLC |
Names and entries exactly as the EDE directory lists them. The directory listed 1,179 products on 20 Oct 2026 and is still being loaded, so treat counts as a floor.